ZA200801227B - Intravenous propofol emulsion compositions having preservative efficacy - Google Patents

Intravenous propofol emulsion compositions having preservative efficacy

Info

Publication number
ZA200801227B
ZA200801227B ZA200801227A ZA200801227A ZA200801227B ZA 200801227 B ZA200801227 B ZA 200801227B ZA 200801227 A ZA200801227 A ZA 200801227A ZA 200801227 A ZA200801227 A ZA 200801227A ZA 200801227 B ZA200801227 B ZA 200801227B
Authority
ZA
South Africa
Prior art keywords
emulsion compositions
preservative efficacy
intravenous propofol
monoglyceryl ester
propofol emulsion
Prior art date
Application number
ZA200801227A
Other languages
English (en)
Inventor
Daftary Gautam Vinod
Pai Srikanth Annappa
Shanbhag Girish Narasimba
Rivankar Sangeeta Hanurmesh
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of ZA200801227B publication Critical patent/ZA200801227B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200801227A 2005-08-05 2008-02-05 Intravenous propofol emulsion compositions having preservative efficacy ZA200801227B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN906MU2005 2005-08-05

Publications (1)

Publication Number Publication Date
ZA200801227B true ZA200801227B (en) 2008-12-31

Family

ID=38006301

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801227A ZA200801227B (en) 2005-08-05 2008-02-05 Intravenous propofol emulsion compositions having preservative efficacy

Country Status (16)

Country Link
US (1) US8759404B2 (es)
EP (1) EP1922060B1 (es)
JP (1) JP2009503059A (es)
KR (1) KR20080043793A (es)
CN (1) CN101304728A (es)
AT (1) ATE420625T1 (es)
AU (1) AU2006310113A1 (es)
BR (1) BRPI0614084A2 (es)
CA (1) CA2618026A1 (es)
DE (1) DE602006004887D1 (es)
EA (1) EA200800258A1 (es)
ES (1) ES2318802T3 (es)
IL (1) IL189310A0 (es)
MX (1) MX2008001746A (es)
WO (1) WO2007052288A2 (es)
ZA (1) ZA200801227B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080262084A1 (en) * 2004-09-13 2008-10-23 Gautam Vinod Daftary Stable Emulsion Compositions for Intravenous Administration Having Preservatie Efficacy
WO2008023384A1 (en) * 2006-08-24 2008-02-28 Bharat Serums & Vaccines Ltd. Propofol emulsion compositions for intravenous administration
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
JP2010163397A (ja) * 2009-01-16 2010-07-29 Japan Ecologia Co Ltd 抗菌性組成物
CN102869345B (zh) 2010-03-17 2015-02-11 诺瓦利克有限责任公司 用于治疗眼内压增高的药物组合物
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
PT2661280T (pt) 2011-01-04 2019-02-25 Novaliq Gmbh Emulsões o/a compreendendo alcanos semifluorados
WO2012160180A2 (en) 2011-05-25 2012-11-29 Novaliq Gmbh Pharmaceutical composition for administration to nails
PL2714010T3 (pl) 2011-05-25 2017-08-31 Novaliq Gmbh Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach
AU2013211645B2 (en) 2012-01-23 2017-06-15 Novaliq Gmbh Stabilised protein compositions based on semifluorinated alkanes
CN102525921B (zh) 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
AU2013249086A1 (en) * 2012-04-20 2014-10-30 Hennepin Life Sciences Compositions for topical treatment of microbial infections
WO2014033751A2 (en) * 2012-08-16 2014-03-06 Emcure Pharmaceuticals Limited Pharmaceutical composition of propofol
EP3181119B1 (en) 2012-09-12 2019-07-10 Novaliq GmbH Semifluorinated alkane compositions for use in the treatment of keratoconjunctivitis sicca
EP2895158B1 (en) 2012-09-12 2019-11-20 Novaliq GmbH Compositions comprising mixtures of semifluorinated alkanes
JP6503349B2 (ja) 2013-07-23 2019-04-17 ノバリック ゲーエムベーハー 安定化された抗体組成物
WO2017001549A1 (en) * 2015-07-01 2017-01-05 Fresenius Kabi Deutschland Gmbh Propofol emulsion for parenteral administration
PT3355990T (pt) 2015-09-30 2019-09-11 Novaliq Gmbh Compostos semifluorados e as suas composições
DE202016008739U1 (de) 2015-09-30 2019-04-29 Novaliq Gmbh Semifluorierte Verbindungen
KR102257916B1 (ko) 2016-06-23 2021-05-28 노바리크 게엠베하 드롭 디스펜서를 포함하는 키트
CN109890374A (zh) 2016-09-22 2019-06-14 诺瓦利克有限责任公司 用于治疗睑缘炎的药物组合物
JP6869336B2 (ja) 2016-09-23 2021-05-12 ノバリック ゲーエムベーハー シクロスポリンを含む眼科用組成物
WO2018193093A1 (en) 2017-04-21 2018-10-25 Novaliq Gmbh Iodine compositions
CN110650734A (zh) 2017-05-12 2020-01-03 诺瓦利克有限责任公司 治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物
CN111372566A (zh) 2017-09-27 2020-07-03 诺瓦利克有限责任公司 用于治疗眼部疾病的包含拉坦前列素的眼科用组合物
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
US20200316043A1 (en) * 2017-12-20 2020-10-08 Aurobindo Pharma Ltd. Pharmaceutical composition comprising clevidipine and process for preparation thereof
WO2019166631A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
CN112823020A (zh) 2018-10-12 2021-05-18 诺瓦利克有限责任公司 用于治疗干眼病的眼用组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
DE69936911T2 (de) * 1998-02-10 2008-05-15 Sicor Inc., Irvine Propofolhaltiges arzneimittel enthaltend sulfite
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140373A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6100302A (en) 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
SE0001865D0 (sv) * 2000-05-19 2000-05-19 Astrazeneca Ab Management of septic shock
GB0012597D0 (en) * 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
IL153457A0 (en) * 2000-06-16 2003-07-06 Skyepharma Canada Inc Improved injectable dispersions of propofol
WO2002043765A2 (en) * 2000-11-28 2002-06-06 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin

Also Published As

Publication number Publication date
WO2007052288A2 (en) 2007-05-10
ATE420625T1 (de) 2009-01-15
CN101304728A (zh) 2008-11-12
CA2618026A1 (en) 2007-05-10
KR20080043793A (ko) 2008-05-19
AU2006310113A1 (en) 2007-05-10
IL189310A0 (en) 2008-06-05
ES2318802T3 (es) 2009-05-01
EA200800258A1 (ru) 2008-06-30
US20070249730A1 (en) 2007-10-25
MX2008001746A (es) 2008-04-07
WO2007052288A3 (en) 2007-08-30
EP1922060B1 (en) 2009-01-14
DE602006004887D1 (de) 2009-03-05
BRPI0614084A2 (pt) 2011-03-09
US8759404B2 (en) 2014-06-24
EP1922060A2 (en) 2008-05-21
JP2009503059A (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
IL189310A0 (en) Intravenous propofol emulsion compositions having preservative efficacy
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
WO2005072343A3 (en) Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use
PH12017501328A1 (en) Self-emulsifying composition of ?-3 fatty acid
EP2387883A3 (en) Antimicrobial compositions comprising benzoic acid
WO2005034908A3 (en) A solid dosage form comprising a fibrate and a statin
EP2345329A3 (en) Micronized wood preservative formulations
MXPA05007813A (es) Composicion con mejor desempeno antimicrobiano para higienizar superficies.
WO2005023233A3 (en) Antimicrobial compositions and methods
WO2004010941A3 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
PL2178504T3 (pl) Roztwór oczny na bazie prostagladyn bez środka konserwującego
DE69926386D1 (de) Propofol-formulierung
MA32638B1 (fr) Procede de lutte contre la degradation d'ingredients actifs chimiques agricoles
WO2007117352A3 (en) Topical therapeutic delivery system
WO2007146683A3 (en) Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
CA2489932A1 (en) Compositions with anisic acid and glycerides
WO2009141548A3 (fr) Composition et procede pour la destruction de polluants organophosphores et/ou organosoufres
IT1320080B1 (it) Composizione per uso farmaceutico o dietetico.
WO2003057153A3 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
ECSP066476A (es) Preparación de una infusión que comprende ácido (2r)-2-propiloctanoico como ingrediente activo
WO2004039326A3 (en) Propofol with cysteine
MX2007002941A (es) Composiciones de emulsion estables para administracion intravenosa que tienen eficacia libre de conservadores.
HK1120412A1 (en) Solid pharmaceutical composition comprising telithromycin
MY140556A (en) Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation